Búsqueda | Portal de Búsqueda de la BVS España

1.

Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL.

Gauthier, Jordan; Gazeau, Nicolas; Hirayama, Alexandre V; Hill, Joshua A; Wu, Vicky; Cearley, Aisling; Perkins, Paula; Kirk, Angela; Shadman, Mazyar; Chow, Victor A; Gopal, Ajay K; Hodges Dwinal, Alexandria; Williamson, Staci; Myers, Jessie; Chen, Andy; Nagle, Sarah; Hayes-Lattin, Brandon; Schachter, Levanto; Maloney, David G; Turtle, Cameron J; Sorror, Mohamed L; Maziarz, Richard T.

Blood; 139(26): 3722-3731, 2022 06 30.

Artículo en Inglés | MEDLINE | ID: mdl-35439295

2.

Abnormal bone marrow findings in patients following treatment with chimeric antigen receptor-T cell therapy.

Yeung, Cecilia C S; Woolston, David W; Wu, Vicky; Voutsinas, Jenna M; Basom, Ryan; Davis, Chris; Hirayama, Alexandre V; Naresh, Kikkeri N.

Eur J Haematol; 112(1): 111-121, 2024 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-37526606

3.

Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.

Gauthier, Jordan; Bezerra, Evandro D; Hirayama, Alexandre V; Fiorenza, Salvatore; Sheih, Alyssa; Chou, Cassie K; Kimble, Erik L; Pender, Barbara S; Hawkins, Reed M; Vakil, Aesha; Phi, Tinh-Doan; Steinmetz, Rachel N; Jamieson, Abby W; Bar, Merav; Cassaday, Ryan D; Chapuis, Aude G; Cowan, Andrew J; Green, Damian J; Kiem, Hans-Peter; Milano, Filippo; Shadman, Mazyar; Till, Brian G; Riddell, Stanley R; Maloney, David G; Turtle, Cameron J.

Blood; 137(3): 323-335, 2021 01 21.

Artículo en Inglés | MEDLINE | ID: mdl-32967009

4.

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure.

Gauthier, Jordan; Hirayama, Alexandre V; Purushe, Janaki; Hay, Kevin A; Lymp, James; Li, Daniel H; Yeung, Cecilia C S; Sheih, Alyssa; Pender, Barbara S; Hawkins, Reed M; Vakil, Aesha; Phi, Tinh-Doan; Steinmetz, Rachel N; Shadman, Mazyar; Riddell, Stanley R; Maloney, David G; Turtle, Cameron J.

Blood; 135(19): 1650-1660, 2020 05 07.

Artículo en Inglés | MEDLINE | ID: mdl-32076701

5.

CD19 occupancy may drive CARs further.

Hirayama, Alexandre V; Bleakley, Marie.

Blood; 143(3): 190-192, 2024 Jan 18.

Artículo en Inglés | MEDLINE | ID: mdl-38236611

6.

High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy.

Hirayama, Alexandre V; Gauthier, Jordan; Hay, Kevin A; Voutsinas, Jenna M; Wu, Qian; Pender, Barbara S; Hawkins, Reed M; Vakil, Aesha; Steinmetz, Rachel N; Riddell, Stanley R; Maloney, David G; Turtle, Cameron J.

Blood; 134(7): 636-640, 2019 08 15.

Artículo en Inglés | MEDLINE | ID: mdl-31648294

7.

Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.

Hay, Kevin A; Gauthier, Jordan; Hirayama, Alexandre V; Voutsinas, Jenna M; Wu, Qian; Li, Daniel; Gooley, Ted A; Cherian, Sindhu; Chen, Xueyan; Pender, Barbara S; Hawkins, Reed M; Vakil, Aesha; Steinmetz, Rachel N; Schoch, Gary; Chapuis, Aude G; Till, Brian G; Kiem, Hans-Peter; Ramos, Jorge D; Shadman, Mazyar; Cassaday, Ryan D; Acharya, Utkarsh H; Riddell, Stanley R; Maloney, David G; Turtle, Cameron J.

Blood; 133(15): 1652-1663, 2019 04 11.

Artículo en Inglés | MEDLINE | ID: mdl-30728140

8.

The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.

Hirayama, Alexandre V; Gauthier, Jordan; Hay, Kevin A; Voutsinas, Jenna M; Wu, Qian; Gooley, Ted; Li, Daniel; Cherian, Sindhu; Chen, Xueyan; Pender, Barbara S; Hawkins, Reed M; Vakil, Aesha; Steinmetz, Rachel N; Acharya, Utkarsh H; Cassaday, Ryan D; Chapuis, Aude G; Dhawale, Tejaswini M; Hendrie, Paul C; Kiem, Hans-Peter; Lynch, Ryan C; Ramos, Jorge; Shadman, Mazyar; Till, Brian G; Riddell, Stanley R; Maloney, David G; Turtle, Cameron J.

Blood; 133(17): 1876-1887, 2019 04 25.

Artículo en Inglés | MEDLINE | ID: mdl-30782611

9.

Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells.

Cordeiro, Ana; Bezerra, Evandro D; Hirayama, Alexandre V; Hill, Joshua A; Wu, Qian V; Voutsinas, Jenna; Sorror, Mohamed L; Turtle, Cameron J; Maloney, David G; Bar, Merav.

Biol Blood Marrow Transplant; 26(1): 26-33, 2020 01.

Artículo en Inglés | MEDLINE | ID: mdl-31419568

10.

Toxicities of CD19 CAR-T cell immunotherapy.

Hirayama, Alexandre V; Turtle, Cameron J.

Am J Hematol; 94(S1): S42-S49, 2019 05.

Artículo en Inglés | MEDLINE | ID: mdl-30784102

11.

Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study.

Wang, Michael; Siddiqi, Tanya; Gordon, Leo I; Kamdar, Manali; Lunning, Matthew; Hirayama, Alexandre V; Abramson, Jeremy S; Arnason, Jon; Ghosh, Nilanjan; Mehta, Amitkumar; Andreadis, Charalambos; Solomon, Scott R; Kostic, Ana; Dehner, Christine; Espinola, Ricardo; Peng, Lily; Ogasawara, Ken; Chattin, Amy; Eliason, Laurie; Palomba, M Lia.

J Clin Oncol; 42(10): 1146-1157, 2024 Apr 01.

Artículo en Inglés | MEDLINE | ID: mdl-38072625

12.

Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma.

Hirayama, Alexandre V; Kimble, Erik L; Wright, Jocelyn H; Fiorenza, Salvatore; Gauthier, Jordan; Voutsinas, Jenna M; Wu, Qian; Yeung, Cecilia C S; Gazeau, Nicolas; Pender, Barbara S; Kirchmeier, Delaney R; Torkelson, Aiko; Chutnik, Abigail N; Cassaday, Ryan D; Chapuis, Aude G; Green, Damian J; Kiem, Hans-Peter; Milano, Filippo; Shadman, Mazyar; Till, Brian G; Riddell, Stanley R; Maloney, David G; Turtle, Cameron J.

Blood Adv; 8(2): 453-467, 2024 01 23.

Artículo en Inglés | MEDLINE | ID: mdl-37903325

13.

CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic review.

Portuguese, Andrew J; Gauthier, Jordan; Tykodi, Scott S; Hall, Evan T; Hirayama, Alexandre V; Yeung, Cecilia C S; Blosser, Christopher D.

Bone Marrow Transplant; 58(4): 353-359, 2023 04.

Artículo en Inglés | MEDLINE | ID: mdl-36575360

14.

A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy.

Hirayama, Alexandre V; Chou, Cassie K; Miyazaki, Takahiro; Steinmetz, Rachel N; Di, Henna A; Fraessle, Simon P; Gauthier, Jordan; Fiorenza, Salvatore; Hawkins, Reed M; Overwijk, Willem W; Riddell, Stanley R; Marcondes, Mario Q; Turtle, Cameron J.

Blood Adv; 7(11): 2479-2493, 2023 06 13.

Artículo en Inglés | MEDLINE | ID: mdl-36332004

15.

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL.

Liang, Emily C; Albittar, Aya; Huang, Jennifer J; Hirayama, Alexandre V; Kimble, Erik L; Portuguese, Andrew J; Chapuis, Aude; Shadman, Mazyar; Till, Brian G; Cassaday, Ryan D; Milano, Filippo; Kiem, Hans-Peter; Riddell, Stanley R; Turtle, Cameron J; Maloney, David G; Gauthier, Jordan.

Blood Adv; 7(22): 6990-7005, 2023 11 28.

Artículo en Inglés | MEDLINE | ID: mdl-37774014

16.

Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy.

Gazeau, Nicolas; Liang, Emily C; Wu, Qian Vicky; Voutsinas, Jenna M; Barba, Pere; Iacoboni, Gloria; Kwon, Mi; Ortega, Juan Luis Reguera; López-Corral, Lucía; Hernani, Rafael; Ortiz-Maldonado, Valentín; Martínez-Cibrian, Nuria; Martinez, Antonio Perez; Maziarz, Richard T; Williamson, Staci; Nemecek, Eneida R; Shadman, Mazyar; Cowan, Andrew J; Green, Damian J; Kimble, Erik; Hirayama, Alexandre V; Maloney, David G; Turtle, Cameron J; Gauthier, Jordan.

Transplant Cell Ther; 29(7): 430-437, 2023 07.

Artículo en Inglés | MEDLINE | ID: mdl-37031746

17.

Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy.

Juluri, Krishna R; Wu, Qian Vicky; Voutsinas, Jenna; Hou, Jue; Hirayama, Alexandre V; Mullane, Erin; Miles, Nancy; Maloney, David G; Turtle, Cameron J; Bar, Merav; Gauthier, Jordan.

Blood Adv; 6(7): 2055-2068, 2022 04 12.

Artículo en Inglés | MEDLINE | ID: mdl-34666344

18.

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia.

Seber, Adriana; de CastroJunior, Claudio Galvão; Kerbauy, Lucila N; Hirayama, Alexandre V; Bonfim, Carmem; Fernandes, Juliana Folloni; Souza, Mair; Schafell, Rony; Nabhan, Samir; Loggetto, Sandra Regina; Simões, Belinda Pinto; Rocha, Vanderson; de Lima, Marcos; Guerino-Cunha, Renato L; Bittencourt, Henrique.

Hematol Transfus Cell Ther; 43 Suppl 2: S13-S21, 2021 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-34794791

19.

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma.

Alencar, Alvaro J; Hirayama, Alexandre V; Clé, Diego V; Salvino, Marco Aurélio; Perini, Guilherme; Arrais, Celso; Baiocchi, Otávio; Palma, Leonardo Carvalho; Colturato, Iago; Vaz, Jorge; Chiattone, Ricardo; de Lima, Marcos; Filho, Jayr Schmidt; Nabhan, Samir; Rocha, Vanderson; Guerino-Cunha, Renato L; Chiattone, Carlos S.

Hematol Transfus Cell Ther; 43 Suppl 2: S22-S29, 2021 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-34794792

20.

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients.

Clé, Diego V; Hirayama, Alexandre V; Alencar, Alvaro J; Costa, Luciano J; Feliciano, João V P; Mattos, Ederson R; Cordeiro, Ana C; Salvino, Marco Aurélio; Barros, George M Navarro; de Lima, Marcos; Scheinberg, Phillip; Guerino-Cunha, Renato L.

Hematol Transfus Cell Ther; 43 Suppl 2: S3-S12, 2021 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-34794793

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: